Human natural killer cell activity is reduced by treatment of anti-myelin-associated glycoprotein (MAG) monoclonal mouse IgM antibody and complement
- 1 December 1985
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 10 (2) , 115-127
- https://doi.org/10.1016/0165-5728(85)90002-5
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Natural killer (NK) cell activity in murine muscular dystrophyClinical Immunology and Immunopathology, 1984
- Molecular characteristics of the epitope in myelin-associated glycoprotein that is recognized by a monoclonal IgM in human neuropathy patientsMolecular Immunology, 1984
- Characterization of human granular lymphocyte subpopulations expressing HNK‐1 (Leu‐7) and Leu‐11 antigens in the blood and lymphoid tissues from fetuses, neonates and adultsEuropean Journal of Immunology, 1984
- A role for natural killer cells in survival: Functions of large granular lymphocytes, including regulation of cell proliferationClinical Immunology and Immunopathology, 1983
- Homeostasis of the Antibody Response: Immunoregulation by NK CellsScience, 1983
- HNK-1 antibody detects an antigen expressed on neuroectodermal cells.The Journal of Experimental Medicine, 1983
- Immunoregulation and natural killer cellsMolecular Immunology, 1982
- Natural Killer Cells: Their Roles in Defenses Against DiseaseScience, 1981
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975
- MYELINATION IN RAT BRAIN: METHOD OF MYELIN ISOLATION1Journal of Neurochemistry, 1973